Shire : SHP

News

• 01 Nov 2018 2 min read

  Fidelity Special Values cuts fees after good year

  Fidelity Special Values cuts fees after good year – Fidelity Special Values has published its results for the year ended 31 August 2018. Its NAV increased by 8.7% over the year and the share price by 14.0%, both well above the 4.7% return of the benchmark index (all on a total return basis). As a result of […]

• 17 Jul 2018 1 min read

  HBM-backed Argenx gets Shire as partner

  HBM-backed Argenx gets Shire as partner Dutch antibody company Argenx (Euronext & Nasdaq:ARGX), a top ten holding for Swiss-listed HBM Healthcare (HBMN, 2.9% of NAV), has gained a new licensing partner with the exercise by Shire Pharmaceuticals of an option held under a 2012 discovery alliance. The license covers a a preclinical stage antibody discovered and […]

• 16 Apr 2018 2 min read

  Shire move leaves BB Healthcare stake in limbo

  Shire disposal leaves BB Healthcare stake in limbo Shire Pharmaceuticals’ announcement this morning of an agreement to sell its oncology business to Servier for $2.4bn in cash, leaves the stake in the company held by BB Healthcare Trust (BBH) – the only sector specialist investment trust to have significant exposure  – in limbo. This is because […]

• 28 Mar 2018 2 min read

  BB Healthcare to benefit from possible Shire takeover

  BB Healthcare to benefit from possible Shire takeover London-listed BB Healthcare Trust (BBH) looks likely to be the main investment trust beneficiary of a potential takeover offer for Shire Pharmaceuticals, which may come about after Takeda released a statement suggesting it was evaluating such a move. Shire, which originated in the UK but is now Irish domiciled and […]

• 27 May 2016 3 min read

  Shires Income’s emerging markets and commodity holdings drive underperformance

  Shires Income, managed by Ed Beal (pictured), has announced its annual results for the year ended 31 March 2016. During the year, the trust’s NAV fell by 7.0% on a total return basis, thereby underperforming its FTSE All-Share Index benchmark, which lost 3.9%. The company says that its NAV underperformance was due principally to stock […]

• 28 Sep 2015 2 min read

  JPMorgan Overseas proposes stock split

  Late on Friday, JPMorgan Overseas published its final results for the year ended 30 June 2012. The total return on net assets for the year was 11.8%, ahead of the total return of 9.5% for the benchmark, the MSCI All Country World Index (in sterling terms). The total return to shareholders was 10.3%. The final dividend […]

• 24 Sep 2015 2 min read

  Widening discount holds back Merchant Trust’s returns

  Merchants Trust reports a 2.8% return on net assets for the six months ended 31 July 2015 and a -1.1% return to shareholders as the discount widened from 0.4% to 4.3%. The return on the FTSE100 Index for the period was 1.2%. Dividends for the first half totalled 12p, 1.7% higher than the pervious year. […]

• 23 Jun 2015 2 min read

  Another great performance from Henderson Opportunities

  Henderson Opportunities has published interim results for the six months ended 30 April 2015. Over that period the FTSE All-Share Index returned 9.2% but the fund’s net asset value returned almost double that, 17.6%. Unfortunately for shareholders though, the discount widened from 3% to 12.1% and so the return to shareholders was just 7.5% – […]

• 09 Jan 2015 1 min read

  Good year for BlackRock Income & Growth

  BlackRock Income & Growth has published its results for the year that ended on 31 October 2014 and over that period the fund outperformed the FTSE All-Share Index, generating a return on net assets of 6.3% against a 1% return for the FTSE All-Share Index. the discount widened slightly and so the return to shareholders […]

• 29 Dec 2014 1 min read

  Schroder UK Growth transition complete

  For the six month period to 31 October 2014, Schroder UK Growth’s NAV saw a total return of -6.3%, while the share price returned -8.8% and the discount widened from 5.2% at the beginning of the period to 7.8% at 31 October 2014. These performance figures compare poorly with an equivalent return of -1.6% by the […]

• 18 Nov 2014 1 min read

  Schroder Income Growth change to investment policy

  SCF : Schroder Income Growth change to investment policy Schroder Income Growth’s annual report for the year that ended on 31 August 2014 is out. they upped the dividend by 3.1% (well ahead of the 1.5% increase in the CPI – inflation beating dividend increases are part of Schroder Income Growth’s objective). The total return […]

• 17 Nov 2014 1 min read

  Decent returns from Standard Life Equity Income

  SLET : Decent returns from Standard Life Equity Income Over the year to the end of September 2014 Standard Life Equity Income managed to beat its benchmark index delivering a total return on net assets of 6.9% and a return to shareholders of 6.3% vs. a 6.1% return on the FTSE All-Share Index. The dividend […]

• 22 Jul 2014 1 min read

  Temple Bar Investment Trust : TMPL – interims

  Over the first half of 2014 Temple Bar Investment Trust, managed by Alastair Mundy (pictured), generated a total return on net assets of 0.3% – slightly behind the return on the FTSE Al-Share Index of 1.6%. the interim dividend has been increased by 3% to 15.55p. The Board has announced that, with effect from January 2015, […]

• 20 Dec 2013 1 min read

  BlackRock Income : BRIG – annual results

  BRIG’s results for the year ended 31 October 2013 show an NAV return of 16.2% and a share price return of 24.3% as compared to a return from the FTSE All-Share Index of 22.8%. BRIG’s total dividend for the year has been increased to 5.5p (from 5.25p) and is now fully covered by revenue. It […]